Otonomy Provides Business and Financial Update
Sep 13, 2017 11:30 am UTC| Business
Actions taken to reduce costs following suspension of OTIVIDEX™ developmentNon-commercial workforce reduced by one-thirdCurrent cash balance expected to fund company into 2020Review underway to prioritize the company's...
Sep 13, 2017 11:30 am UTC| Business
- Company’s Actimab-A and Actimab-M programs to be presented at the conference NEW YORK, Sept. 13, 2017 -- Actinium Pharmaceuticals, Inc (NYSE American:ATNM) (“Actinium” or “the Company”), a biopharmaceutical company...
Sep 13, 2017 11:30 am UTC| Business
PARSIPPANY, N.J., Sept. 13, 2017 -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX), today announced a collaboration with Aetna, one of the nation’s leading diversified health care benefits companies, with the support of the...
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
Sep 13, 2017 11:30 am UTC| Business
DUBLIN, Ireland, Sept. 13, 2017 -- Avadel Pharmaceuticals plc (NASDAQ:AVDL), today announced that management will present at two upcoming investor conferences: The Ladenburg Thalmann 2017 Healthcare Conference on...
Ascendant Resources Launches Virtual Tour of the El Mochito Mine
Sep 13, 2017 11:30 am UTC| Business
TORONTO, Sept. 13, 2017 -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("Ascendant" or the "Company”) is pleased to announce the launch of its 360° virtual tour of the El Mochito Mine located in...
Sep 13, 2017 11:00 am UTC| Business
HAIFA, Israel, Sept. 13, 2017 -- Pluristem Therapeutics Inc. (NASDAQ:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, announced today that the company has been issued two new patents by...
Sep 13, 2017 11:00 am UTC| Business
MILAN, Italy, Sept. 13, 2017 -- FibroGen, Inc. (NASDAQ:FGEN), a science-based biopharmaceutical company, announced today positive results from the company’s Phase 2b randomized, double-blind, placebo-controlled study...